Chime School

Efavirenz, emtricitabine, and tenofovir are approved individually by the FDA for the treatment of HIV infection in adults. In addition Efavirenz and Emtricitabine are approved for use in children who are infected with HIV.  These three medicines are frequently prescribed together, the manufacturers have combined them into one tablet. Atripla (Tenovir/Emtricitabine/Efavirenz) came onto the market in July of 2006 as a FDA approved treatment for HIV. Atripla may be used as a complete regimen or in combination with other anti retroviral.

As a result Atripla has become a leading medication in the fight against HIV/AIDS and has helped people living with HIV a great deal. This helps to make dealing with HIV simplier and the drug regimens more effective because it reduces forgotten doses. This reduces the number of drug resistant mutations that can occur.

Atripla (Viraday) does not cure or prevent HIV infection or HIV and does not reduce the risk of passing the virus to other people. Atripla can causes a number of unwanted side effects. More serious side effects of Efavirenz are confusion, depression, abnormal thinking, hallucinations, memory loss, thoughts of suicide, and paranoid thinking. Some people can develop a bad rash. The NRTIs in Atripla can cause a sometimes fatal lactic acidosis and liver disease as well as blood problems or muscle weakness. You should tell your doctor if while taking Atripla you suffer from pain in your joints, muscles, stomach and weakness, trouble with breathing, nausea, a feeling of cold, dizziness, irregular heartbeat, jaundice, dark urine and loss of appetite. Patients should notify their doctor if they have any of the side effects listed. Side effects that are not as severe can lessen or disappear with continued use. Patients should notify their doctor if side effects continue or worsen. If you have hepatitis B you should pay attention if you stop taking Atripla because this may cause a adverse reaction.

Comments are closed.